Alogliptin + metformin

Trade Name: 
Kazano
Manufacturer/Distributor: 
Takeda Canada
www.takedacanada.com
Classification: 
Oral antihyperglycemic agent
DPP-4 inhibitor
Incretin enhancer
ATC Class: 
A10BH - dipetidyl peptidase 4 (DPP-4) inhibitor
Status: 
active
Notice of Compliance (yyyy/mm/dd): 
2013/11/27
Date Marketed in Canada (yyyy/mm/dd): 
2014/10/08
Presentation: 
tablet: alogliptin 12.5 mg + metformin 500 mg. DIN: 02417219
tablet: alogliptin 12.5 mg + metformin 850mg. DIN: 02417227
tablet: alogliptin 12.5 mg + metformin 1000mg. DIN: 02417235
Comments: 
Indicated to improve glycemic control in adult patients with type 2 diabetes mellitus.